Published in J Microencapsul on August 01, 2005
Mucoadhesive microspheres for gastroretentive delivery of acyclovir: in vitro and in vivo evaluation. AAPS J (2008) 1.07
Quantification of the CBD-FITC conjugates surface coating on cellulose fibres. BMC Biotechnol (2008) 0.79
Strategies to improve plasma half life time of peptide and protein drugs. Amino Acids (2006) 1.75
Thiolated polymers--thiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates. Biomaterials (2001) 1.35
Bioadhesive microspheres for ophthalmic administration of acyclovir. J Pharm Pharmacol (1997) 1.06
Development and in vitro evaluation of a mucoadhesive vaginal delivery system for progesterone. J Control Release (2001) 1.05
Gamma irradiation effects on poly(DL-lactictide-co-glycolide) microspheres. J Control Release (1998) 1.04
Long-term release of clodronate from biodegradable microspheres. AAPS PharmSciTech (2001) 1.04
Gamma irradiation effects on stability of poly(lactide-co-glycolide) microspheres containing clonazepam. J Control Release (2001) 0.98
Oral peptide drug delivery: polymer-inhibitor conjugates protecting insulin from enzymatic degradation in vitro. Biomaterials (2000) 0.96
Different molecular weight chitosan microspheres: influence on drug loading and drug release. Drug Dev Ind Pharm (1998) 0.96
Poly(lactide-co-glycolide) microspheres containing bupivacaine: comparison between gamma and beta irradiation effects. J Control Release (2003) 0.95
Mucoadhesive and cohesive properties of poly(acrylic acid)-cysteine conjugates with regard to their molecular mass. Eur J Pharm Sci (2003) 0.95
Diaminobenzidine photoconversion is a suitable tool for tracking the intracellular location of fluorescently labelled nanoparticles at transmission electron microscopy. Eur J Histochem (2012) 0.93
Effect of nanoparticle encapsulation on the photostability of the sunscreen agent, 2-ethylhexyl-p-methoxycinnamate. Int J Pharm (2002) 0.91
Evaluation and improvement of the properties of the novel cystine-knot microprotein McoEeTI for oral administration. Int J Pharm (2006) 0.91
Prevalence and risk indicators for destructive periodontal diseases in 3 urban American minority populations. J Clin Periodontol (2001) 0.91
Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats. J Control Release (2013) 0.89
gamma-Irradiation of PEGd,lPLA and PEG-PLGA multiblock copolymers. I. Effect of irradiation doses. AAPS PharmSciTech (2008) 0.89
Design and in vivo evaluation of an oral delivery system for insulin. Pharm Res (2000) 0.88
Cloning and sequence analysis of the X-prolyl-dipeptidyl-aminopeptidase gene (pepX) from Lactobacillus delbrückii ssp. lactis DSM7290. Appl Microbiol Biotechnol (1993) 0.88
Thiolated carboxymethylcellulose: in vitro evaluation of its permeation enhancing effect on peptide drugs. Eur J Pharm Biopharm (2001) 0.88
Periodontal delivery of ipriflavone: new chitosan/PLGA film delivery system for a lipophilic drug. Int J Pharm (2003) 0.88
Use of polylactic acid for the preparation of microparticulate drug delivery systems. J Microencapsul (1992) 0.87
Development and in vivo bioavailability study of an oral fondaparinux delivery system. Eur J Pharm Sci (2010) 0.87
Spray-dried albumin microspheres for the intra-articular delivery of dexamethasone. J Microencapsul (1994) 0.85
Synthesis, characterization, mucoadhesion and biocompatibility of thiolated carboxymethyl dextran-cysteine conjugate. J Control Release (2010) 0.85
Emulsion spray-drying for the preparation of albumin-loaded PLGA microspheres. Drug Dev Ind Pharm (2001) 0.85
Improvement of the intestinal membrane permeability of low molecular weight heparin by complexation with stem bromelain. Int J Pharm (2006) 0.85
Thiomer-coated liposomes harbor permeation enhancing and efflux pump inhibitory properties. J Control Release (2012) 0.85
Liposomes containing boronophenylalanine for boron neutron capture therapy. J Microencapsul (1998) 0.85
Preparation and characterization of ampicillin loaded methylpyrrolidinone chitosan and chitosan microspheres. Biomaterials (1998) 0.85
Analysis of some Malaysian dart poisons. J Ethnopharmacol (1992) 0.84
Gamma irradiation effects and EPR investigation on poly(lactide-co-glycolide) microspheres containing bupivacaine. Farmaco (2002) 0.84
The fate of indefinite and low-grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation. Aliment Pharmacol Ther (2013) 0.83
Evaluation of process parameters involved in chitosan microsphere preparation by the o/w/o multiple emulsion method. J Microencapsul (1997) 0.83
Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microsphere preparation. J Microencapsul (1994) 0.83
Correlation of in vitro and in vivo models for the oral absorption of peptide drugs. Amino Acids (2007) 0.83
Study on glycolic acid delivery by liposomes and microspheres. Int J Pharm (2000) 0.83
Induction of an in vitro reversible hypometabolism through chitosan-based nanoparticles. J Microencapsul (2011) 0.82
Preparation of thiomer microparticles and in vitro evaluation of parameters influencing their mucoadhesive properties. Drug Dev Ind Pharm (2006) 0.82
Development and in vivo evaluation of an oral insulin-PEG delivery system. Eur J Pharm Sci (2004) 0.82
Clonazepam microencapsulation in poly-D,L-lactide-co-glycolide microspheres. J Microencapsul (1998) 0.81
Modification of the expression of adenosine 3',5'-cyclic monophosphate-induced differentiated functions in neuroblastoma cells by beta-carotene and D-alpha-tocopheryl succinate. J Am Coll Nutr (1994) 0.81
Comparative in vivo mucoadhesion studies of thiomer formulations using magnetic resonance imaging and fluorescence detection. J Control Release (2006) 0.80
The antistaphylococcal effect of nisin in a suitable vehicle: a potential therapy for atopic dermatitis in man. J Pharm Pharmacol (1996) 0.80
Improvement of the enzymatic stability of a cytotoxic T-lymphocyte-epitope model peptide for its oral administration. Peptides (2002) 0.80
Characterisation of the barrier caused by luminally secreted gastro-intestinal proteolytic enzymes for two novel cystine-knot microproteins. Amino Acids (2007) 0.80
Microparticulate drug delivery systems. EXS (1999) 0.80
Non-viral dried powders for respiratory gene delivery prepared by cationic and chitosan loaded liposomes. Int J Pharm (2008) 0.79
Thiolated polycarbophil as an adjuvant for permeation enhancement in nasal delivery of antisense oligonucleotides. J Pharm Sci (2010) 0.79
Characterisation of the thiol-disulphide chemistry of desmopressin by LC, mu-LC, LC-ESI-MS and Maldi-Tof. Amino Acids (2005) 0.79
Site-directed PEGylation as successful approach to improve the enzyme replacement in the case of prolidase. Int J Pharm (2008) 0.79
Long-term effect of gamma irradiation on the functional properties and cytocompatibility of multiblock co-polymer films. J Biomater Sci Polym Ed (2012) 0.79
Direct compressible polymethacrylic acid-starch compositions for site-specific drug delivery. J Control Release (2001) 0.79
Thiolated polyacrylic acid-modified iron oxide nanoparticles for in vitro labeling and MRI of stem cells. J Drug Target (2010) 0.78
Sub-unit vaccine against S. aureus-mediated infections: set-up of nano-sized polymeric adjuvant. Int J Pharm (2013) 0.78
gamma-irradiation of PEGd,lPLA and PEG-PLGA multiblock copolymers: II. effect of oxygen and EPR investigation. AAPS PharmSciTech (2008) 0.78
Efficacy of oleuropein against UVB irradiation: preliminary evaluation. Int J Cosmet Sci (2008) 0.78
Poly(D,L-lactide) nanoencapsulation to reduce photoinactivation of a sunscreen agent. Int J Cosmet Sci (2008) 0.77
In vitro evaluation of the permeation-enhancing effect of thiolated polycarbophil. J Pharm Sci (2000) 0.77
Enzyme loaded biodegradable microspheres in vitro ex vivo evaluation. J Control Release (2001) 0.77
Preliminary evaluation of particle systems visualization on the skin surface by scanning electron microscopy and transparency profilometry. Skin Res Technol (2011) 0.77
[Phytotoxicity of hydrazones of aromatic aldehydes]. Farmaco Sci (1976) 0.77
PLGA microspheres for oral osteopenia treatment: preliminary "in vitro"/"in vivo" evaluation. Int J Pharm (2003) 0.77
Hyaluronidase-injectable microparticles intended for the treatment of extravasation. J Microencapsul (1998) 0.77
Nasal delivery of antisense oligonucleotides: in vitro evaluation of a thiomer/glutathione microparticulate delivery system. J Drug Target (2010) 0.77
Polyethylenglycol-co-poly-D,L-lactide copolymer based microspheres: preparation, characterization and delivery of a model protein. J Microencapsul (2008) 0.76
Evaluation of official instrumental methods for the determination of particulate matter contamination in large volume parenteral solutions. J Pharm Pharmacol (1986) 0.76
Deoxycholate-hydrogels: novel drug carrier systems for topical use. Int J Pharm (1999) 0.76
Design of 3D scaffolds for tissue engineering testing a tough polylactide-based graft copolymer. Mater Sci Eng C Mater Biol Appl (2013) 0.75
Auxiliary agents for the peroral administration of peptide and protein drugs: synthesis and evaluation of novel pepstatin analogues. J Med Chem (1998) 0.75
Biodegradable microspheres for prolidase delivery to human cultured fibroblasts. J Pharm Pharmacol (2004) 0.75
Evaluation of the influence of open and closed-ampoule technologies on particulate matter in small-volume parenterals. J Parenter Sci Technol (1994) 0.75
[Aryl esters of N-benzyldithiocarbamic acid with antimycotic activity]. Farmaco Sci (1983) 0.75
[Effects of perhexiline maleate in angina pectoris: preliminary clinical and experimental results of a comparative study]. Boll Soc Ital Cardiol (1975) 0.75
[The contamination of large volume parenteral solutions by foreign particles. Proposal for updating the Italian regulations]. Farmaco Prat (1986) 0.75
[Derivatives of 2-thiocyanobenzoic acid with antifungal activity]. Farmaco Sci (1984) 0.75
Antigravitropic activity of 2-(2-arylamino-1,2-dioxoethyl) benzoic acid methyl esters. Farmaco (1994) 0.75
Antimycotic agents: evaluation of some derivatives of 2-thiocyanobenzoic acid. Farmaco Sci (1985) 0.75
Antimycotic 2-alkyldithio, 2-aralkyldithio, 2-aryldithiobenzamides. Farmaco Sci (1985) 0.75
Evaluation of enzyme stability during preparation of polylactide-co-glycolide microspheres. J Microencapsul (2002) 0.75